MedPath

Assessment of efficacy of neuronavigated theta burst stimulation in obsessive compulsive disorder patient

Phase 3
Conditions
Health Condition 1: F422- Mixed obsessional thoughts and acts
Registration Number
CTRI/2019/07/020366
Lead Sponsor
Central institute of psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Diagnosis of Obsessive-Compulsive Disorder using Diagnostic Criteria for Research (DCR) of International Classification of Disease-10th edition (ICD-10, World Health Organization,1992)

2.Age between 18- 60 years of either sex

3.Right handed

4.Patients giving written informed consent

Exclusion Criteria

1.OCD with severe depression as measured by HAM D score > 23

2.Presence of co-morbid neurological or other psychiatric disorder(s).

3.Patient with co morbid substance dependence, except nicotine and caffeine.

4.Patient on any psychotropic medications.

5.Having any metallic implants/parts in body.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome of the study in change in severity of obsession and compulsion assessed at 0 week and at the end of 3 week of Theta Burst stimulation with the specially designed score sheet.Timepoint: YBOCS, HAM-D, HAM-A, CGI will be applied at the starting of intervention followed by assessment at 3 weeks and finally on follow up at 8 weeks
Secondary Outcome Measures
NameTimeMethod
Changes in levels of psychopathology as measured by HAM-D, HAM-A and CGITimepoint: Baseline, 03 weeks and 08 weeks post intervention
© Copyright 2025. All Rights Reserved by MedPath